{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:39:32Z","timestamp":1791848372205,"version":"4.3.4"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Bile acids (BAs) are synthesized in the liver and extensively modified by gut microbiota in the intestine. The dynamic composition of the BA pool enables BAs to modulate metabolic responses at varying degrees. By activating nuclear (e.g., FXR) and membrane (e.g., TGR5) receptors, BAs integrate metabolic and immune processes across the enterohepatic circulation and peripheral tissues, forming a systemic homeostatic network. Dysregulation of this network is causally linked to metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus, and other disorders. Targeting BA signaling has shown therapeutic potential in preclinical studies, though clinical translation requires further exploration. This review elucidates the dynamic composition of the BA pool, the integrated regulatory roles of BA signaling networks in health and disease, and highlights emerging therapeutic strategies that target the BA signaling\u2014including FXR agonists, TGR5 modulators, and microbiota-derived BA interventions\u2014for metabolic and immune-mediated diseases.<\/jats:p>","DOI":"10.3389\/fendo.2026.1890710","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:45Z","timestamp":1784867085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bile acid signaling: from dynamic pool composition to inter-organ communication"],"prefix":"10.3389","volume":"17","author":[{"given":"Fuyu","family":"Yang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikuan","family":"Chu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01570-0","article-title":"Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids","volume":"9","author":"Liu","year":"2024","journal-title":"Nat Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2022.100275","article-title":"Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3\u03b2-hydroxy bile acids in feces","volume":"63","author":"Takei","year":"2022","journal-title":"J Lipid Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.cell.2024.02.019","article-title":"The underappreciated diversity of bile acid modifications","volume":"187","author":"Mohanty","year":"2024","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06990-w","article-title":"Bile salt hydrolase catalyses formation of amine-conjugated bile acids","volume":"626","author":"Rimal","year":"2024","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-023-2353-0","article-title":"Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis","volume":"67","author":"Jia","year":"2024","journal-title":"Sci China Life Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2192155","article-title":"Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes","volume":"15","author":"Chen","year":"2023","journal-title":"Gut Microbes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"G549","DOI":"10.1152\/ajpgi.00152.2020","article-title":"Bile acid metabolism and circadian rhythms","volume":"319","author":"Yang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08379-9","article-title":"Host metabolism balances microbial regulation of bile acid signalling","volume":"638","author":"Won","year":"2025","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.243","article-title":"Novel microbial modifications of bile acids and their functional implications","volume":"3","author":"Zheng","year":"2024","journal-title":"Imeta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2024-100074","article-title":"Bile acids regulation of cellular stress responses in liver physiology and diseases","volume":"2","author":"Li","year":"2024","journal-title":"eGastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s42003-024-06321-3","article-title":"Comparative profiling of serum, urine, and feces bile acids in humans, rats, and mice","volume":"7","author":"Zheng","year":"2024","journal-title":"Commun. Biol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.06.009","article-title":"Bile acid and nonalcoholic steatohepatitis: molecular insights and therapeutic targets","volume":"59","author":"Cheng","year":"2024","journal-title":"J Adv Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114001","article-title":"Integrative analysis of the gut microbiota, bile acid pathways, and immune dysregulation in dyslipidemia models","volume":"28","author":"Xia","year":"2025","journal-title":"iScience"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjnut.2024.12.035","article-title":"Secondary bile acid derivatives are contributors to the fecal bile acid pool and associated with bile acid-modulating nutrients","volume":"155","author":"Wolf","year":"2025","journal-title":"J Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00018-022-04509-6","article-title":"New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.8.637","article-title":"Diurnal changes in serum unconjugated bile acids in normal man","volume":"23","author":"Setchell","year":"1982","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.009","article-title":"Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis","volume":"129","author":"G\u00e4lman","year":"2005","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10014","DOI":"10.1038\/s41467-024-53673-9","article-title":"Exposing 24-hour cycles in bile acids of male humans","volume":"15","author":"Bello","year":"2024","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.029","article-title":"Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice","volume":"55","author":"Sberna","year":"2011","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313153","article-title":"Differential actions of muscarinic receptor subtypes in gastric, pancreatic, and colon cancer","volume":"22","author":"Schledwitz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1016\/j.cell.2025.05.010","article-title":"A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPRE","volume":"188","author":"Lin","year":"2025","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1021\/acs.jmedchem.6b01126","article-title":"Discovery of 3\u03b1,7\u03b1,11\u03b2-Trihydroxy-6\u03b1-ethyl-5\u03b2-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders","volume":"59","author":"Pellicciari","year":"2016","journal-title":"J Med Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"151453","DOI":"10.1016\/j.bbrc.2025.151453","article-title":"Python-derived 16\u03b1-Hydroxylated Bile Acid, Pythocholic Acid is a ligand for TGR5, not farnesoid X receptors and vitamin D receptors","volume":"751","author":"Kiaei","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1021\/jm070633p","article-title":"Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5","volume":"50","author":"Pellicciari","year":"2007","journal-title":"J Med Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100073","article-title":"Pathological and therapeutic roles of bile acid metabolism and signaling in hepatocellular carcinoma: insights from human and mouse studies","volume":"77","author":"Wang","year":"2025","journal-title":"Pharmacol Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.421834","article-title":"Nuclear receptors HNF4\u03b1 and LRH-1 cooperate in regulating Cyp7a1 in vivo","volume":"287","author":"Kir","year":"2012","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","article-title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31724","article-title":"Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump","volume":"35","author":"Plass","year":"2002","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"G774","DOI":"10.1152\/ajpgi.00387.2024","article-title":"Hepatic and intestinal tissue-specific Fxr deficiency alters bile acid homeostasis in female mice","volume":"328","author":"Jiang","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J Adv Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.1c04035","article-title":"Novel \u03b9-carrageenan tetrasaccharide alleviates liver lipid accumulation via the bile acid-FXR-SHP\/PXR pathway to regulate cholesterol conversion and fatty acid metabolism in insulin-resistant mice","volume":"69","author":"Li","year":"2021","journal-title":"J Agric Food Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.083899","article-title":"Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia","volume":"285","author":"Zhang","year":"2010","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01036-5","article-title":"Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy","volume":"6","author":"Wang","year":"2024","journal-title":"Nat Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.11.011","article-title":"Mechanism of action of the bile acid receptor TGR5 in obesity","volume":"14","author":"Lun","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109726","article-title":"Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling","volume":"36","author":"Hu","year":"2021","journal-title":"Cell Rep"},{"key":"B64","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.jpha.2023.12.005","article-title":"Traditional Chinese medicine Pien-Tze-Huang ameliorates LPS-induced sepsis through bile acid-mediated activation of TGR5-STAT3-A20 signalling","volume":"14","author":"Li","year":"2024","journal-title":"J Pharm Anal"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2120744","article-title":"Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota","volume":"14","author":"Jin","year":"2022","journal-title":"Gut Microbes"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0327","article-title":"Taurocholic acid promotes hepatic stellate cell activation via S1PR2\/p38 MAPK\/YAP signaling under cholestatic conditions","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.2939","article-title":"Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR\/ERK1\/2 signaling pathway","volume":"46","author":"Amonyingcharoen","year":"2015","journal-title":"Int J Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000295","article-title":"Meta-analysis reveals the prognostic relevance of nuclear and membrane-associated bile acid receptors in gastric cancer","volume":"12","author":"Rohr","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.025155","article-title":"Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes","volume":"37","author":"Han","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.027","article-title":"Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol","volume":"146","author":"Chow","year":"2014","journal-title":"Gastroenterology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41598-020-58644-w","article-title":"Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog Lipid Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156340","article-title":"Schisandrol B alleviates depression-like behavior in mice by regulating bile acid homeostasis in the brain-liver-gut axis via the pregnane X receptor","volume":"137","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1274","article-title":"Constitutive androstane receptor differentially regulates bile acid homeostasis in mouse models of intrahepatic cholestasis","volume":"3","author":"Kim","year":"2019","journal-title":"Hepatol Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-023-36981-4","article-title":"Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy","volume":"14","author":"Tang","year":"2023","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.699504","article-title":"Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet \u03b1 cells to promote glucose homeostasis","volume":"291","author":"Kumar","year":"2016","journal-title":"J Biol Chem"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2465896","article-title":"Increased dietary protein stimulates amino acid catabolism via the gut microbiota and secondary bile acid production","volume":"17","author":"Tob\u00f3n-Cornejo","year":"2025","journal-title":"Gut Microbes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01067-8","article-title":"Bile acid metabolism in type 2 diabetes mellitus","volume":"21","author":"Cadena Sandoval","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2011.11.010","article-title":"Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia","volume":"15","author":"Haeusler","year":"2012","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.lfs.2019.05.031","article-title":"The alterations of bile acids in rats with high-fat diet\/streptozotocin-induced type 2 diabetes and their negative effects on glucose metabolism","volume":"229","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.166231","article-title":"The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt\/beta-catenin pathways","volume":"285","author":"Abdelkarim","year":"2010","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41467-017-02068-0","article-title":"TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue","volume":"9","author":"Velazquez-Villegas","year":"2018","journal-title":"Nat Commun"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2023.0277","article-title":"Glucagon-like peptide-1: New regulator in lipid metabolism","volume":"48","author":"Bu","year":"2024","journal-title":"Diabetes Metab J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13017","article-title":"Targeting bile acid metabolism in obesity reduction: A systematic review and meta-analysis","volume":"21","author":"So","year":"2020","journal-title":"Obes Rev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102766","article-title":"A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility","volume":"55","author":"Wei","year":"2020","journal-title":"EBioMedicine"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.03.038","article-title":"Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice","volume":"11","author":"Ding","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/metabo7020028","article-title":"Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer's disease","volume":"7","author":"Pan","year":"2017","journal-title":"Metabolites"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1038\/s41467-025-60331-1","article-title":"Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling","volume":"16","author":"Bruce","year":"2025","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00617","article-title":"Bile acid signaling pathways from the enterohepatic circulation to the central nervous system","volume":"11","author":"Mertens","year":"2017","journal-title":"Front Neurosci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.09.003","article-title":"GLP-1 programs the neurovascular landscape","volume":"36","author":"Chen","year":"2024","journal-title":"Cell Metab"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02227-2","article-title":"The role of gut microbial metabolites in the T cell lifecycle","volume":"26","author":"Tran","year":"2025","journal-title":"Nat Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa9420","article-title":"Mucosal immunology. Individual intestinal symbionts induce a distinct population of ROR\u03b3+ regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1172\/jci129401","article-title":"Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation","volume":"130","author":"Bhargava","year":"2020","journal-title":"J Clin Invest"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.cell.2025.02.029","article-title":"Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity","volume":"188","author":"Jin","year":"2025","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.adl4100","article-title":"Bile acid synthesis impedes tumor-specific T cell responses during liver cancer","volume":"387","author":"Varanasi","year":"2025","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-4425","article-title":"Gut microbiota-mediated bile acid metabolism regulates colorectal cancer liver metastasis by altering neutrophil recruitment","volume":"85","author":"Zheng","year":"2025","journal-title":"Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2024.101291","article-title":"Immunology of bile acids regulated receptors","volume":"95","author":"Fiorucci","year":"2024","journal-title":"Prog Lipid Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156175","article-title":"Yi-Fei-San-Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5\/STAT3\/PD-L1 axis in lung cancer","volume":"135","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401630R","article-title":"Integrative analysis of non12-hydroxylated bile acid revealed the suppressed molecular map of alternative pathway in nonalcoholic steatohepatitis mice","volume":"38","author":"Feng","year":"2024","journal-title":"Faseb j"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"B109","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3350\/cmh.2024.0782","article-title":"Bioactive metabolites: A clue to the link between MASLD and CKD?","volume":"31","author":"Chen","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102582","article-title":"Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice","volume":"59","author":"Zhuge","year":"2023","journal-title":"Redox Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuy031","article-title":"Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"76","author":"Loman","year":"2018","journal-title":"Nutr Rev"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2020.03.013","article-title":"Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review","volume":"16","author":"Talavera-Urquijo","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2026.100115","article-title":"Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases","volume":"78","author":"Ding","year":"2026","journal-title":"Pharmacol Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157172","article-title":"Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway","volume":"147","author":"Hu","year":"2025","journal-title":"Phytomedicine"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29050976","article-title":"Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin","volume":"29","author":"Xu","year":"2024","journal-title":"Molecules"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1007\/s10753-025-02294-5","article-title":"Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice","volume":"48","author":"Goto","year":"2025","journal-title":"Inflammation"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147784","article-title":"The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice","volume":"25","author":"Nonogaki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113937","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice","volume":"147","author":"Hu","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.2337\/db17-1502","article-title":"Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21","volume":"67","author":"Kim","year":"2018","journal-title":"Diabetes"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbaf017","article-title":"Tetrahedral framework nucleic acids ameliorate cholestatic liver disease by activating Wnt\/\u03b2-catenin signaling and promoting ERK1\/2 phosphorylation","volume":"12","author":"Zhou","year":"2025","journal-title":"Regener Biomater"},{"key":"B128","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146973","article-title":"Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation","volume":"851","author":"You","year":"2023","journal-title":"Gene"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001438","article-title":"Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease","volume":"82","author":"Trauner","year":"2025","journal-title":"Hepatology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001032","article-title":"IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon","volume":"82","author":"Sutton","year":"2025","journal-title":"Hepatology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.06.010","article-title":"The history and future of bile acid therapies","author":"Beuers","year":"2025","journal-title":"J Hepatol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/s0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"B134","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/s2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1194\/jlr.M081935","article-title":"FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver","volume":"59","author":"Papazyan","year":"2018","journal-title":"J Lipid Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.069","article-title":"Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor","volume":"595","author":"Jiang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.10.001","article-title":"Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.bbalip.2019.05.014","article-title":"Hepatocyte peroxisome proliferator-activated receptor \u03b1 regulates bile acid synthesis and transport","volume":"1864","author":"Xie","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102056","article-title":"Selective PPAR\u03b4 agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway","volume":"298","author":"Kouno","year":"2022","journal-title":"J Biol Chem"},{"key":"B141","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-111717-122956","article-title":"Clinical application and potential of fecal microbiota transplantation","volume":"70","author":"Ooijevaar","year":"2019","journal-title":"Annu Rev Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11112793","article-title":"Therapeutic effects of zymomonas mobilis on experimental DSS-induced colitis mouse model","volume":"11","author":"Almo","year":"2023","journal-title":"Microorganisms"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826746","article-title":"B. adolescentis ameliorates chronic colitis by regulating Treg\/Th2 response and gut microbiota remodeling","volume":"13","author":"Fan","year":"2021","journal-title":"Gut Microbes"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317596121","article-title":"The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis","volume":"121","author":"Dong","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B151","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41419-020-02819-w","article-title":"Farnesoid X receptor antagonizes Wnt\/\u03b2-catenin signaling in colorectal tumorigenesis","volume":"11","author":"Yu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1638352","article-title":"Interplay between bile acids, gut microbiota, and the tumor immune microenvironment: mechanistic insights and therapeutic strategies","volume":"16","author":"Tong","year":"2025","journal-title":"Front Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00288-25","article-title":"Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis","volume":"10","author":"Hao","year":"2025","journal-title":"mSystems"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads9705","article-title":"Metabolic surgery reduces CRC disease progression through circulating bile acid diversion","volume":"17","author":"L\u00e4ssle","year":"2025","journal-title":"Sci Transl Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2025-100227","article-title":"Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR","volume":"3","author":"Henry","year":"2025","journal-title":"eGastroenterology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1890710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:47Z","timestamp":1784867087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1890710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":155,"alternative-id":["10.3389\/fendo.2026.1890710"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1890710","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1890710"}}